Estimates Revisions Alvotech Nasdaq Stockholm
Stocks
ALVO SDB
SE0025011463
Biotechnology & Medical Research
|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 38.40 SEK | -0.26% |
|
+6.96% | -17.31% |
| 08-18 | Calendar Wednesday, August 19 | FW |
| 07-30 | Alvotech Announces Successful Closure Of U.S Food and Drug Administration Inspection Of Manufacturing Facility | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
| - | ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- ALVO Stock
- ALVO SDB Stock
- Consensus Alvotech
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
















